v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (58,499) $ (44,316)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 3,724 3,063
Stock-based compensation expense 27,606 22,271
Non-cash lease adjustment (318) (254)
Provision for credit losses 604 900
Inventory write-down 706 490
(Gain) loss on foreign currency transactions 431 (348)
Changes in operating assets and liabilities:    
Accounts receivable (24,948) 1,223
Inventory (6,828) (11,068)
Prepaid expenses and other current assets 1,966 1,089
Other assets (835) (1,165)
Accounts payable (1,316) 1,504
Accrued compensation (2,726) (5,248)
Accrued interest expense 100 52
Loan facility liability 0 (2,000)
Deferred revenue 984 223
Other liabilities 1,971 1,561
Net cash used in operating activities (57,378) (32,023)
Cash flows from investing activities:    
Purchases of property and equipment (5,867) (4,638)
Net cash used in investing activities (5,867) (4,638)
Cash flows from financing activities:    
Proceeds from issuance of common stock from the exercise of stock options 405 2,171
Proceeds from the issuance of common stock under employee stock purchase plan 4,313 3,505
Net cash provided by financing activities 4,718 5,676
Effect of exchange rates on cash, cash equivalents and restricted cash (62) (23)
Net decrease in cash, cash equivalents and restricted cash (58,589) (31,008)
Beginning of the period 289,541 336,763
End of the period 230,952 305,755
Reconciliation of cash, cash equivalents and restricted cash to balance sheets:    
Cash and cash equivalents 227,914 302,717
Restricted cash 3,038 3,038
Cash, cash equivalents and restricted cash in balance sheets 230,952 305,755
Supplemental cash flow information    
Interest paid 1,590 1,754
Non-cash investing and financing activities    
Property and equipment included in accounts payable and accrued expenses $ 121 $ 613